New Group Leaders in Structural Biology
The year is off to a good start for our Structural Biology Research Centre, with the arrival of three new Group Leaders following the open recruitment call which opened in April 2020.
Francesca Coscia, an Italian biochemist and Cryo-EM expert currently at the Medical Research Council Laboratory of Molecular Biology in Cambridge, UK. Her research focuses on the molecular mechanisms behind thyroid function and disease. She has already started a collaboration with HT and will be joining full time in May 2021.
Philipp Erdmann is a German chemical biologist and microscopist. After five years as a project group leader at the Max Plank Institute for Biochemistry in Martinsried, Germany, he has joined HT in February 2021. At HT his lab will focus on the analysis of liquid-liquid phase separation (LLPS) effects using in situ cryo-electron tomography. LLPS is often involved in crucial processes of both transmittable and non-transmittable human diseases, including virus infections and neurodegenerative disorders.
Ana Casañal is a Spanish biochemist and integrated structural biology expert with a focus on Cryo-EM. Since 2014, she has been a postdoctoral researcher leading Cryo-EM projects at the Medical Research Council Laboratory of Molecular Biology in Cambridge, UK. At HT her group will combine cutting edge Cryo-EM with biochemical and biophysical methods to unravel the mechanisms of mRNA processing machines to help reveal how their deregulation impacts human disease. She will be joining HT in March 2021.
We are excited to have Francesca, Philipp and Ana join HT and we look forward to welcoming them to Milan.
Share:
You could also like:
-
Colorectal Cancer: ML Enhances Cetuximab Response Predictions
An international collaborative study led by Human Technopole, Candiolo Cancer Institute IRCCS in Turin, the University of Turin, and the Wellcome Sanger Institute in Cambridge (UK) has identified new factors associated with therapeutic response in colorectal cancer. The research has led to the development of a machine-learning model capable of accurately predicting the effects of cetuximab, a drug in clinical use, on different colorectal tumour subtypes. Funded by the AIRC Foundation, the study paves the way to identifying molecular features that could serve as biomarkers for predicting treatment response in patients with this type of cancer.
-
Human Technopole Foundation’s Supplier List online
The Human Technopole Foundation’s Supplier Register is now online.
-
HT Director Zerial Awarded Mercurio Prize for Excellence in Research
The Human Technopole Director, Marino Zerial, has been awarded the 2024 Mercurio Prize in the “Research and Development” category, in recognition of the excellence of his research in the field of cell biology. Zerial, renowned for his studies on the mechanisms of endocytosis and cellular transport, has made significant contributions to the understanding of cellular dynamics, with potential therapeutic applications for diseases such as liver conditions.
-
A new model system for cortical development in vitro
Researchers from Human Technopole, the Institute of Molecular Biotechnology and Bicocca University established a method for developing brain assembloids that allows reproducing salient aspects of the antero-posterior polarity of the human cerebral cortex in vitro and opens new possibilities for disease modelling. The study is published in Nature Methods.
-
The National Facility for Genomics with Clelia Peano
Meet Clelia Peano, Head of the National Facility for Genomics. The Facility offers cutting-edge services to develop robust experimental and analytical workflows to explore different genomic research areas, including DNA and RNA analysis, chromatin structure, and epigenetic mechanisms regulating transcription. The goal is to enhance genomic research in all its aspects, benefiting the entire Italian scientific community.